← All organizations
Highest phase reached
Phase 2
First clinical trial
Oct 25, 2017Last known activity
Oct 3, 2022
Timeline
2010s
- Jun 1, 2016
Eirion Therapeutics— Founded
Drugs by trial phase (2 distinct, 6 trials)
Phase 2 (2 own, 0 via acquisition)
Recent trials (11)
- NCT05565950Lead sponsorPhase 1/Phase 2Oct 3, 2022
- NCT04985916Study directorPhase 2Jul 19, 2021
- NCT04985916Lead sponsorPhase 2Jul 19, 2021
- NCT03912805Lead sponsorPhase 2Feb 28, 2019
- NCT03912805Study directorPhase 2Feb 28, 2019
- NCT03839693Study directorPhase 2Oct 16, 2018
- NCT03839693Lead sponsorPhase 2Oct 16, 2018
- NCT03655691Lead sponsorPhase 2Aug 16, 2018
- NCT03655691Study directorPhase 2Aug 16, 2018
- NCT03326856Lead sponsorPhase 2Oct 25, 2017
- NCT03326856Study directorPhase 2Oct 25, 2017
Details
- Founded
- Woburn, MA, US Jun 1, 2016
- Last known activity
- Oct 3, 2022